Clostridium difficile(Sarum)(Clostridium difficile(Sarum)) - 在研适应症：艰难梭菌感染_专利_临床

概要

基本信息

药物类型

噬菌体疗法

别名-

靶点-

作用方式-

作用机制-

治疗领域

感染

在研适应症

艰难梭菌感染

非在研适应症-

原研机构

Sarum Biosciences

在研机构

Sarum Biosciences

非在研机构-

权益机构-

最高研发阶段临床前

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

100 项与 Clostridium difficile(Sarum) 相关的临床结果

登录后查看更多信息

100 项与 Clostridium difficile(Sarum) 相关的转化医学

登录后查看更多信息

100 项与 Clostridium difficile(Sarum) 相关的专利（医药）

登录后查看更多信息

2

项与 Clostridium difficile(Sarum) 相关的文献（医药）

2016-09-01·The Lancet Respiratory Medicine

Calls to suspend European sales of erlotinib for lung cancer

作者: Tanday, Sanjay

guidelines are beneficial to patients as shorter antibiotic use will eradicate the infection while reducing the risk of antibiotic-related side-eff ects such as Clostridium diffi cile. They will also help to fi ght against antibiotic resistance and generate cost savings both to patients and to society.” Richard Russell, from the British Lung Foundation (London, UK), said that short courses of antibiotics might be acceptable for use in the UK following this evidence review. “I hope that these new evidence statements can be reviewed for local UK guidance, and will make a diff erence. They clearly state that antibiotic policy should be made locally, due to bacteria prevalence and resistance patterns, which diff er. This is similar to the UK and is an important principle”, he said.

2008-02-01·The Lancet Infectious Diseases1区 · 医学

There's the rub: infection control that spreads infection

1区 · 医学

Article

作者: Dixon, Bernard

Last March, when I fi rst wrote about acinetobacter on this page, it was bad news. Today, it looks like worse news. The organism that still has not entered the journalist’s lexicon alongside meticillin-resistant Staphylococcus aureus (MRSA) and Clostridium diffi cile could prove to be an even more intractable cause of hospital infections. The latest blow is that a key element in the battle against nosocomial infection—alcohol-based handrubs—may make matters worse rather than better. A year ago (Lancet Infect Dis 2007; 7: 181), Acinetobacter baumannii was attracting attention for three reasons. First, it is a formidable opportunistic pathogen, especially in critically ill patients needing mechanical ventilation. Second, the bacterium has evolved extraordinarily effi cient mechanisms for acquiring and over-expressing resistance genes. Finally, it is highly refractory to both vigorous cleaning and to disinfectants.

100 项与 Clostridium difficile(Sarum) 相关的药物交易

登录后查看更多信息